BioHarvest Sciences Statistics
Total Valuation
BHST has a market cap or net worth of $111.23 million. The enterprise value is $117.63 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BHST has 22.65 million shares outstanding. The number of shares has increased by 13.20% in one year.
| Current Share Class | 22.65M |
| Shares Outstanding | 22.65M |
| Shares Change (YoY) | +13.20% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 14.75% |
| Owned by Institutions (%) | 0.61% |
| Float | 17.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.61 |
| Forward PS | 5.93 |
| PB Ratio | 12.45 |
| P/TBV Ratio | 14.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 2.24.
| Current Ratio | 1.35 |
| Quick Ratio | 1.02 |
| Debt / Equity | 2.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.70 |
Financial Efficiency
Return on equity (ROE) is -200.22% and return on invested capital (ROIC) is -19.22%.
| Return on Equity (ROE) | -200.22% |
| Return on Assets (ROA) | -12.58% |
| Return on Invested Capital (ROIC) | -19.22% |
| Return on Capital Employed (ROCE) | -27.92% |
| Weighted Average Cost of Capital (WACC) | 9.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.07 |
| Inventory Turnover | 3.50 |
Taxes
In the past 12 months, BHST has paid $148,000 in taxes.
| Income Tax | 148,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.82% in the last 52 weeks. The beta is 1.18, so BHST's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -8.82% |
| 50-Day Moving Average | 5.68 |
| 200-Day Moving Average | 7.42 |
| Relative Strength Index (RSI) | 41.35 |
| Average Volume (20 Days) | 40,244 |
Short Selling Information
The latest short interest is 33,198, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 33,198 |
| Short Previous Month | 70,472 |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.19% |
| Short Ratio (days to cover) | 1.06 |
Income Statement
In the last 12 months, BHST had revenue of $32.72 million and -$11.89 million in losses. Loss per share was -$0.68.
| Revenue | 32.72M |
| Gross Profit | 19.37M |
| Operating Income | -6.14M |
| Pretax Income | -11.74M |
| Net Income | -11.89M |
| EBITDA | -5.41M |
| EBIT | -6.14M |
| Loss Per Share | -$0.68 |
Full Income StatementBalance Sheet
The company has $10.97 million in cash and $17.36 million in debt, with a net cash position of -$6.40 million or -$0.28 per share.
| Cash & Cash Equivalents | 10.97M |
| Total Debt | 17.36M |
| Net Cash | -6.40M |
| Net Cash Per Share | -$0.28 |
| Equity (Book Value) | 7.74M |
| Book Value Per Share | 0.39 |
| Working Capital | 4.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.36 million and capital expenditures -$2.09 million, giving a free cash flow of -$9.46 million.
| Operating Cash Flow | -7.36M |
| Capital Expenditures | -2.09M |
| Free Cash Flow | -9.46M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
Gross margin is 59.21%, with operating and profit margins of -18.77% and -36.33%.
| Gross Margin | 59.21% |
| Operating Margin | -18.77% |
| Pretax Margin | -35.88% |
| Profit Margin | -36.33% |
| EBITDA Margin | -16.53% |
| EBIT Margin | -18.77% |
| FCF Margin | n/a |
Dividends & Yields
BHST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.20% |
| Shareholder Yield | -13.20% |
| Earnings Yield | -10.69% |
| FCF Yield | -8.50% |
Analyst Forecast
The average price target for BHST is $14.00, which is 185.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 185.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Jun 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
BHST has an Altman Z-Score of -1.18 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.18 |
| Piotroski F-Score | 3 |
